ONEMEDNET CORPORATION Net Income
ONEMEDNET CORPORATION (ONMD) reported Net Income of -$2.17 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Income Statement › Net Income
us-gaap:NetIncomeLoss · last filed 2026-08-14
- ONEMEDNET CORPORATION net income (loss) attributable to parent for the quarter ending 2026-06-30 was -$2.17M, a 172.84% decline year-over-year.
- ONEMEDNET CORPORATION net income (loss) attributable to parent for the quarter ending 2026-03-31 was -$2.45M.
- ONEMEDNET CORPORATION net income (loss) attributable to parent for the quarter ending 2025-12-31 was -$3.14M.
- ONEMEDNET CORPORATION net income (loss) attributable to parent for the quarter ending 2025-09-30 was -$741.00K.
- ONEMEDNET CORPORATION net income (loss) attributable to parent for fiscal 2023 was -$33.78M.
- ONEMEDNET CORPORATION net income (loss) attributable to parent for fiscal 2022 was -$30.45M.
| Period end | Net Income (Loss) Attributable to Parent 2 month | Net Income (Loss) Attributable to Parent 3 month | Net Income (Loss) Attributable to Parent 3 month as first filed | Net Income (Loss) Attributable to Parent 5 month | Net Income (Loss) Attributable to Parent 6 month | Net Income (Loss) Attributable to Parent 6 month as first filed | Net Income (Loss) Attributable to Parent 8 month | Net Income (Loss) Attributable to Parent 9 month | Net Income (Loss) Attributable to Parent 9 month as first filed | Net Income (Loss) Attributable to Parent 11 month | Net Income (Loss) Attributable to Parent 12 month | Net Income (Loss) Attributable to Parent 12 month as first filed |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$2.17M 10-Q · filed 2026-08-14 | -$4.63M 10-Q · filed 2026-08-14 | -$7.76M derived: sum of 3 quarters · filed 2026-08-14 | -$8.51M derived: sum of 4 quarters · filed 2026-08-14 | ||||||||
| 2026-03-31 | -$2.45M 10-Q · filed 2026-08-14 | -$5.59M derived: sum of 2 quarters · filed 2026-08-14 | -$6.33M derived: sum of 3 quarters · filed 2026-08-14 | -$3.35M derived: sum of 4 quarters · filed 2026-08-14 | ||||||||
| 2025-12-31 | -$3.14M derived: S-1/A 12 month − 10-Q 9 month · filed 2026-07-08 | -$3.88M derived: sum of 2 quarters · filed 2026-07-08 | -$899.00K derived: sum of 3 quarters · filed 2026-08-14 | -$2.80M S-1/A · filed 2026-07-08 | ||||||||
| 2025-09-30 | -$741.00K 10-Q · filed 2025-11-14 | $2.24M derived: sum of 2 quarters · filed 2026-08-14 | $339.00K 10-Q · filed 2025-11-14 | -$2.03M derived: sum of 4 quarters · filed 2026-08-14 | ||||||||
| 2025-06-30 | $2.98M 10-Q · filed 2026-08-14 | $1.08M 10-Q · filed 2026-08-14 | -$1.29M derived: sum of 3 quarters · filed 2026-08-14 | -$3.35M derived: sum of 4 quarters · filed 2026-08-14 | ||||||||
| 2025-03-31 | -$1.90M 10-Q · filed 2026-08-14 | -$4.28M derived: sum of 2 quarters · filed 2026-08-14 | -$6.33M derived: sum of 3 quarters · filed 2026-08-14 | -$9.92M derived: sum of 4 quarters · filed 2026-08-14 | ||||||||
| 2024-12-31 | -$2.37M derived: S-1/A 12 month − 10-Q 9 month · filed 2026-07-08 | -$4.43M derived: sum of 2 quarters · filed 2026-07-08 | -$8.02M derived: sum of 3 quarters · filed 2026-07-08 | -$10.13M S-1/A · filed 2026-07-08 | ||||||||
| 2024-09-30 | -$2.06M 10-Q · filed 2025-11-14 | -$5.65M derived: sum of 2 quarters · filed 2025-11-14 | -$7.76M 10-Q · filed 2025-11-14 | -$7.75M 10-Q · filed 2024-12-17 | -$10.25M derived: sum of 4 quarters · filed 2025-11-14 | |||||||
| 2024-06-30 | -$3.59M 10-Q · filed 2025-11-14 | -$5.70M 10-Q · filed 2025-08-13 | -$8.19M derived: sum of 3 quarters · filed 2025-11-14 | -$22.03M derived: sum of 4 quarters · filed 2025-11-14 | ||||||||
| 2024-03-31 | -$2.11M 10-Q · filed 2025-11-14 | -$4.61M derived: sum of 2 quarters · filed 2025-11-14 | -$18.45M derived: sum of 3 quarters · filed 2025-11-14 | -$28.05M derived: sum of 4 quarters · filed 2025-11-14 | ||||||||
| 2023-12-31 | -$2.50M derived: 10-K 12 month − 10-Q 9 month · filed 2025-04-15 | -$16.34M derived: sum of 2 quarters · filed 2025-04-15 | -$25.94M derived: sum of 3 quarters · filed 2025-04-15 | -$33.78M 10-K · filed 2025-04-15 | -$23.21M 10-K · filed 2024-04-09 | |||||||
| 2023-09-30 | -$13.84M 10-Q · filed 2024-12-17 | -$1.69M 10-Q · filed 2023-11-20 | -$23.44M derived: sum of 2 quarters · filed 2024-12-17 | -$31.28M 10-Q · filed 2024-12-17 | -$4.96M 10-Q · filed 2023-11-20 | -$39.34M derived: sum of 4 quarters · filed 2024-12-17 | ||||||
| 2023-06-30 | -$9.60M 10-Q · filed 2024-12-17 | -$5.16K 10-Q · filed 2023-08-14 | -$17.44M 10-Q · filed 2024-12-11 | -$91.14K 10-Q · filed 2023-08-14 | -$25.50M derived: sum of 3 quarters · filed 2024-12-17 | -$34.24M derived: sum of 4 quarters · filed 2024-12-17 | ||||||
| 2023-03-31 | -$7.84M 10-Q · filed 2024-12-17 | -$85.98K 10-Q · filed 2023-05-19 | -$15.89M derived: sum of 2 quarters · filed 2024-12-17 | -$24.64M derived: sum of 3 quarters · filed 2024-12-17 | -$23.69M derived: sum of 4 quarters · filed 2024-12-17 | |||||||
| 2022-12-31 | -$8.05M derived: 10-K/A 12 month − 8-K/A 9 month · filed 2024-11-05 | -$16.80M derived: sum of 2 quarters · filed 2024-11-22 | -$15.85M derived: sum of 3 quarters · filed 2024-11-22 | -$30.45M 10-K/A · filed 2024-11-05 | $336.66K 10-K · filed 2023-03-31 | |||||||
| 2022-09-30 | -$8.74M 8-K/A · filed 2024-11-22 | -$153.28K 10-Q · filed 2022-11-18 | -$7.80M derived: sum of 2 quarters · filed 2024-11-22 | -$22.40M 8-K/A · filed 2024-11-22 | $2.99M 10-Q · filed 2022-11-18 | |||||||
| 2022-06-30 | $949.94K 10-Q · filed 2023-08-14 | $3.15M 10-Q/A · filed 2023-12-18 | $3.15M 10-Q · filed 2022-08-15 | |||||||||
| 2022-03-31 | $2.20M 10-Q · filed 2023-08-14 | |||||||||||
| 2021-12-31 | $5.14M 10-K · filed 2023-03-31 | |||||||||||
| 2021-09-30 | $1.29M 10-Q · filed 2022-11-18 | $5.60M derived: sum of 2 quarters · filed 2022-11-18 | $5.60M 10-Q · filed 2022-11-18 | |||||||||
| 2021-06-30 | $4.31M 10-Q · filed 2022-08-15 | $4.31M 10-Q · filed 2022-11-18 | ||||||||||
| 2021-03-31 | -$845.00 10-Q/A · filed 2021-07-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| FOXO TECHNOLOGIES INC. (FOXO) | United States | $0.000B | -277.71 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |